Meyer Children's Hospital

Running trials

• Recruiting

  Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

  NCT07817875· Phase 3· Eli Lilly and Company· Source

• Not yet recruiting

  Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial

  NCT07699107· Phase 4· Nisha Acharya· Source

• Not yet recruiting

  Standardized Italian netwoRk Enrolling iNdividuals With Islet-Autoantibodies

  NCT07503366· Società Italiana di Endocrinologia e Diabetologia Pediatrica· Source

• Not yet recruiting

  MASKd: a Study on Kawasaki Disease (KD) Complicated by Macrophage Activation Syndrome (MAS)

  NCT07491926· Meyer Children's Hospital IRCCS· Source

• Recruiting

  REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

  NCT07412782· Meyer Children's Hospital IRCCS· Source

• Recruiting

  ASMact: Study on Management of Bronchial Asthma

  NCT07412769· Meyer Children's Hospital IRCCS· Source

• Recruiting

  GenoDrugP 2025: Study on Three-dimensional Models Derived From Brain Tumors in Pediatric Patients

  NCT07417072· Meyer Children's Hospital IRCCS· Source

• Recruiting

  TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders

  NCT07377032· Phase 3· Meyer Children's Hospital IRCCS· Source

• Recruiting

  SLIT ABS: Study on Patients With Autoimmune Podocytopathy

  NCT07516964· Meyer Children's Hospital IRCCS· Source

• Recruiting

  EFESO: Study on Juvenile Onset Eosinophilic Fasciitis

  NCT07348263· Meyer Children's Hospital IRCCS· Source

• Recruiting

  KETO-TUMOR: a Study on Brain Tumors and Central Obesity

  NCT07396896· Meyer Children's Hospital IRCCS· Source

• Recruiting

  An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

  NCT05066217· Phase 3· Epygenix· Source

• Recruiting

  MICRO-BRAIN 2024: Study on Pediatric Brain Tumors

  NCT07417085· Meyer Children's Hospital IRCCS· Source

• Recruiting

  A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  NCT06672549· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Auto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease

  NCT06849622· Meyer Children's Hospital IRCCS· Source

• Recruiting

  Functional MRI During Resting State in Patients with Eating Disorders

  NCT06874348· Meyer Children's Hospital IRCCS· Source

• Active, not recruiting

  Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II

  NCT06392009· Phase 1/2· GRIN Therapeutics, Inc.· Source

• Recruiting

  Multi-biomarkers in DEE

  NCT07909382· Istituto Giannina Gaslini· Source

• Recruiting

  A Study of Pitolisant in Patients With Prader-Willi Syndrome

  NCT06366464· Phase 3· Harmony Biosciences Management, Inc.· Source

• Active, not recruiting

  Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy

  NCT05803434· Phase 2· Meyer Children's Hospital IRCCS· Source

• Recruiting

  Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.

  NCT06862843· Meyer Children's Hospital IRCCS· Source

• Recruiting

  Psychotropic-Drug-induced QT Prolongation and ECG Monitoring in the Pediatric Population

  NCT06870006· Meyer Children's Hospital IRCCS· Source

• Recruiting

  A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease

  NCT06092034· Phase 2· Rocket Pharmaceuticals Inc.· Source

• Active, not recruiting

  24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

  NCT05677451· Phase 3· Novartis Pharmaceuticals· Source

• Recruiting

  Validation, Implementation, and Cost-analysis of a Strategy for Personalized Diagnosis of Rare Kidney Diseases

  NCT06324136· Meyer Children's Hospital IRCCS· Source

• Recruiting

  Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age

  NCT06289660· Meyer Children's Hospital IRCCS· Source

• Recruiting

  Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).

  NCT06297512· Phase 2· Iacopo Sardi· Source

• Active, not recruiting

  Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder

  NCT05373719· Loulou Foundation· Source

• Recruiting

  Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

  NCT05416307· Phase 2/3· Electra Therapeutics Inc.· Source

• Active, not recruiting

  Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma (JLS)

  NCT07908108· Istituto Giannina Gaslini· Source

• Recruiting

  RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age

  NCT06273748· Meyer Children's Hospital IRCCS· Source

• Recruiting

  AutoInflammatory Disease Alliance Registry (AIDA)

  NCT05200715· University of Siena· Source

• Active, not recruiting

  Communication Memory of Cancer Diagnosis Within the Pediatric Triangle

  NCT04392908· Meyer Children's Hospital IRCCS· Source

• Recruiting

  Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas

  NCT04621201· Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna· Source

• Recruiting

  International Rare Histiocytic Disorders Registry (IRHDR)

  NCT02285582· The Hospital for Sick Children· Source

• Recruiting

  Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

  NCT00315380· University of Pennsylvania· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers6 recruiting
• Obesity4 recruiting
• Epilepsy3 recruiting
• Uveitis3 recruiting
• Haemophagocytic lymphohistiocytosis2 recruiting
• Type 1 diabetes2 recruiting
• ANCA-associated vasculitis1 recruiting
• Anorexia nervosa1 recruiting
• Asthma1 recruiting
• Bulimia nervosa1 recruiting
• Chronic kidney disease1 recruiting
• Coeliac disease1 recruiting
• Crohn's disease1 recruiting
• Cushing's syndrome1 recruiting
• Glioblastoma1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Nephrotic syndrome1 recruiting
• Osteoporosis1 recruiting
• Sarcoma1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Tuberculosis1 recruiting
• Type 2 diabetes1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC OLE)

  NCT05604170· Phase 3· Marinus Pharmaceuticals Inc.· Source

• Recruiting

  Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

  NCT05219617· Phase 3· SK Life Science, Inc.· Source

• Terminated

  A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome

  NCT05163314· Phase 3· Takeda· Source

• Completed

  A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome

  NCT04938427· Phase 3· Takeda· Source

• Completed

  A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome

  NCT04940624· Phase 3· Takeda· Source

• Completed

  Coping and Post Traumatic Distress in Children and Adolescents During Cancer Follow-up Care

  NCT04908020· Meyer Children's Hospital IRCCS· Source

• Terminated

  Self-Management Of Asthma By Forced Oscillation Technique

  NCT04963140· Restech Srl· Source

• Completed

  Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

  NCT04029480· Phase 3· Merck Sharp & Dohme LLC· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Epilepsy47 works · 9 trials
• Hypertrophic cardiomyopathy40 works · 1 trial
• Cystic fibrosis18 works · 0 trials
• Eosinophilic oesophagitis9 works · 0 trials
• Uveitis7 works · 3 trials
• Fabry disease7 works · 0 trials
• Thalassaemia6 works · 0 trials
• Pompe disease5 works · 0 trials
• Coeliac disease5 works · 1 trial
• Nephrotic syndrome5 works · 1 trial
• Haemophagocytic lymphohistiocytosis4 works · 2 trials
• ANCA-associated vasculitis4 works · 1 trial
• Gaucher disease3 works · 0 trials